Other

Biodics

Michael Moos

Christoph Von Eichel-Streiber

Veit Braun

Christoph Von Eichelstreiber

Karina Gisch

The method for detecting and identifying a variantstrain in a sample is characterized by the following steps: (a) obtaining a sample of excreta or tissue from a human or animal patient body; (b) bringing the sample into contact with at least one antibody from each of at least three of the antibody groups group I, group II, group III, group IV, group V and group VI; (c) detecting the antibody reaction and constructing the reaction pattern; (d) comparing the reaction pattern obtained in (c) with reference patterns from knownstrains andstrains the presence of which is to be tested in the investigation test; (e) assessing the agreement between the reaction pattern obtained in (c) and the reference pattern as indicative of the presence of thestrain of the reference pattern concerned in the sample.

[object Object]

The invention relates to monoclonal antibodies capable of recognizing and neutralizing epitopes from the ligand domain, the translocation domain or the catalytic domain of the enterotoxin (toxin A) and cytotoxin (toxin B) from, as well as their production and therapeutic and prophylactic applications to diseases caused by said toxins.

The invention relates to monoclonal antibodies capable of recognizing and neutralizing epitopes from the ligand domain, the translocation domain or the catalytic domain of the enterotoxin (toxin A) and cytotoxin (toxin B) from , as well as their production and therapeutical and prophylactic applications to diseases due to the toxins.

Growing community of inventors

Mainz, Germany

Michael Moos